ORIGINAL INVESTIGATION. Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period

ORIGINAL INVESTIGATION Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period Alison E. Field, ScD; Eugenie H. Coakley; Aviva Must, PhD; Jennifer L. Spadano, MA; Nan Laird, PhD; William H. Dietz, MD, PhD; Eric Rimm, ScD; Graham A. Colditz, MD, DrPH Background: Overweight adults are at an increased risk of developing numerous chronic diseases. Methods: Ten-year follow-up (1986-1996) of middleaged women in the Nurses Health Study and men in the Health Professionals Follow-up Study to assess the health risks associated with overweight. Results: The risk of developing diabetes, gallstones, hypertension, heart disease, and stroke increased with severity of overweight among both women and men. Compared with their same-sex peers with a body mass index (BMI) (calculated as weight in kilograms divided by the square of height in meters) between 18.5 and 24.9, those with BMI of 35.0 or more were approximately 20 times more likely to develop diabetes (relative risk [RR], 17.0; 95% confidence interval [CI], 14.2-20.5 for women; RR, 23.4; 95% CI, 19.4-33.2 for men). who were overweight but not obese (ie, BMI between 25.0 and 29.9) were also significantly more likely than their leaner peers to develop gallstones (RR, 1.9), hypertension (RR, 1.7), high cholesterol level (RR, 1.1), and heart disease (RR, 1.4). The results were similar in men. Conclusions: During 10 years of follow-up, the incidence of diabetes, gallstones, hypertension, heart disease, colon cancer, and stroke (men only) increased with degree of overweight in both men and women. Adults who were overweight but not obese (ie, 25.0 BMI 29.9) were at significantly increased risk of developing numerous health conditions. Moreover, the dose-response relationship between BMI and the risk of developing chronic diseases was evident even among adults in the upper half of the healthy weight range (ie, BMI of 22.0-24.9), suggesting that adults should try to maintain a BMI between 18.5 and 21.9 to minimize their risk of disease. Arch Intern Med. 2001;161:1581-1586 From the Channing Laboratory, Department of Medicine, Brigham and s Hospital and Harvard Medical School, Boston, Mass (Drs Field, Rimm, and Colditz); JSI Research and Training, Boston (Ms Coakley); Department of Family Medicine and Community Health, Tufts University School of Medicine, Boston (Dr Must); US Department of Agriculture, Human Nutrition Research Center on Aging at Tufts University (Dr Must and Ms Spadano); Departments of Biostatistics (Dr Laird), Nutrition (Dr Rimm), and Epidemiology (Drs Rimm and Colditz), Harvard School of Public Health, Boston; and Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, Atlanta, Ga (Dr Dietz). IN THE UNITED STATES, obesity has become a serious public health problem. According to the third National Health and Nutrition Examination Survey, 32% of adults in the United States are overweight and an additional 22.5% are obese. 1 Moreover, the prevalence of obesity has been increasing sharply among children and adults during the past 3 decades, and the trend is expected to continue. 2 Overweight and obesity are risk factors for cardiovascular disease, 3 certain cancers, 4-6 diabetes, 7 and mortality. 8,9 In addition, overweight also exacerbates many other chronic diseases, such as hypertension, 10 osteoarthritis, 11,12 gallstones, 13 dyslipidemia, and musculoskeletal problems. 14,15 Unfortunately, comparison of results across epidemiologic studies has been difficult because of the lack of consensus on weight categories. Further complicating the issue is that the new US dietary guidelines and the World Health Organization now define overweight as a body mass index (BMI) (calculated as weight in kilograms divided by the square of height in meters) of 25 or more, a major shift downward from the old US cutoffs of 27.3 for women and 27.8 for men. The US dietary guidelines classify BMI as follows: less than 18.5 is underweight, 18.5 to 24.9 is the healthy weight range, 25.0 to 29.9 is moderately overweight, and 30.0 or more is severely overweight or obese. 16 Since a relatively large proportion of the population has a BMI between 25.0 and 27.0, the change in cutoff for overweight has resulted in a substantial increase in the prevalence of overweight. Moreover, the change has resulted in some confusion regarding the health risks associated with overweight (ie, BMI of 25.0-29.9), since a sizable proportion of this group was previously considered to have a healthy weight. The majority of articles with original data, as opposed to review articles, on the health risks of obesity have limited themselves to a few health outcomes. Al- 1581

METHODS THE NURSES HEALTH STUDY The Nurses Health Study was established in 1976, when 121701 female registered nurses from across the United States, aged 30 to 55 years, answered a mailed questionnaire on risk factors for cancer and heart disease. Questionnaires, mailed to these women every other year since 1976, ask about diagnosis during the past 2 years, as well as a wide variety of lifestyle factors including diet, physical activity, smoking, and contraception. For diseases of particular interest, we write to the nurse to obtain permission to review the medical records pertaining to the diagnosis. In addition, all women reporting diabetes are sent a supplementary questionnaire to obtain additional information regarding the symptoms and diagnosis. Several repeated mailings are sent to nonrespondents, and these are followed by telephone interviews. In instances where we cannot obtain the medical records, we attempt to acquire as much information as possible to code a disease as probable, even if definite confirmation cannot be achieved. For deceased participants, we write to the next of kin to obtain permission to review the medical records. The records are reviewed by medically trained personnel according to established criteria. HEALTH PROFESSIONALS FOLLOW-UP STUDY The Health Professionals Follow-up Study is a prospective study of 51529 men, aged 40 to 75 years when the study began in 1986. Follow-up questionnaires are sent biennially to update information on exposure and disease. The follow-up has been greater than 90% through the 1994 questionnaire cycle. The follow-up procedures for medical diagnoses are similar to those used in the Nurses Health Study. VALIDITY OF DIAGNOSES OF HYPERTENSION, HIGH CHOLESTEROL LEVEL, AND DIABETES Diagnoses of hypertension, high cholesterol level, and diabetes are not confirmed by medical record review. However, we have conducted validation studies of persons in the Nurses Health Study and Health Professionals Follow-up Study cohorts and found that the diagnoses are accurately reported. Among a sample of women participating in the Nurses Health Study who reported a diagnosis of hypertension and participated in the validation study, all had blood pressure greater than 140/90 mm Hg. 17 In an age-stratified sample of 161 nurses in the Nurses Health Study who lived in the greater Boston area and had never reported a diagnosis of hypertension, only 7% had blood pressure greater than 140/90 mm Hg, but none was greater than 160/95 mm Hg. In the same validation study, there was an approximately 14% false-positive rate for hypercholesterolemia. The false-negative rate was estimated to be approximately 15.5% among a sample of the 181 nurses in the Boston, Mass, area without a previous self-reported diagnosis of hypercholesterolemia. The validity of a self-reported diagnosis of diabetes was investigated in a sample of 61 women participating in the Nurses Health Study. The diagnosis of type 2 diabetes mellitus was confirmed by medical records in 60 (98.4%) of the women. In another substudy to assess the prevalence of undiagnosed diabetes, fasting plasma glucose and plasma fructosamine were measured in a random sample of participants who did not report a previous diagnosis of diabetes. though this is the standard approach for epidemiologic articles, providing data on multiple outcomes is the most efficient way to illustrate the impact of overweight on physical health. To assess the adverse impact of overweight, we have analyzed the 10-year associated risks of developing high cholesterol level, hypertension, gallstones, type 2 diabetes, heart disease, stroke, and colon cancer among women in the Nurses Health Study and men in the Health Professionals Follow-up Study, 2 large ongoing prospective cohort studies. RESULTS The mean age in the 2 cohorts was similar (52.9 vs 54.5 years for women and men, respectively), and both cohorts were predominantly white ( 93%); however, the prevalences of obesity (BMI in 1986, 30.0) (14.8% vs 8.2%) and current smoking (21.1% vs 9.9%) were higher among the women than the men (Table 1). During 10 years of follow-up, more than half of the men and women were diagnosed as having high blood pressure (16% of women and 19% of men) or high cholesterol level (49% of women and 48% of men) (Table 2). In addition, approximately 2% of the women and 3% of the men developed diabetes. Gallstones were diagnosed more often during a 10-year period among the women (7.8% vs 3.5%), whereas heart disease was more common among the men (5.2% vs 3.4%). In both cohorts, the risk of developing diabetes, gallstones, hypertension, heart disease, and stroke increased with severity of overweight. Among both women and men, those with a BMI of 35.0 or more were approximately 20 times more likely to develop diabetes (relative risk [RR], 17.0; 95% confidence interval [CI], 14.2-20.5 for women; RR, 23.4; 95% CI, 19.4-33.2 for men) than their same-sex peers with a BMI between 18.5 and 24.9. Moreover, adults who were overweight but not obese (ie, BMI between 25.0 and 29.9) were more than 3 times as likely as their leaner peers to develop diabetes during 10 years (Table 3). who were overweight but not obese were also significantly more likely than their leaner peers to develop gallstones (RR, 1.9; 95% CI, 1.7-2.0), hypertension (RR, 1.7; 95% CI, 1.6-1.7), high cholesterol level (RR, 1.1; 95% CI, 1.1-1.2), and heart disease (RR, 1.4; 95% CI, 1.2-1.5). The associations with the development of colon cancer and stroke were elevated but not significant. The results were similar in men, with the exception that obese men were significantly more likely to have a stroke (RR, 2.0) during the 10 years of follow-up. Among both women and men, the risks of developing 1582

Only 1 (0.5%) of the women had an elevated fasting plasma glucose or plasma fructosamine level in the diabetic range, and her levels were barely above the diagnostic cutoffs. By confirming all self-reported cases of diabetes, we exclude false-positive results, and the Nurses Health Study results suggest that the false-negative rate is low. Therefore, we feel confident that the women in the sample are correctly classified by the self-report questionnaire and subsequent follow-up. The validity of self-report of diabetes has been tested in a subsample of 71 men from the Health Professionals Follow-up Study who reported newly diagnosed diabetes between 1996 and 1998. A physician blinded to the information reported on the supplementary questionnaire reviewed the records according to the revised diagnostic criteria. Of the 71 patients, 12 had incomplete records, eg, absent laboratory data (n=3) or 1 set of laboratory data only (n=9). All 12 had records that were strongly suggestive of diabetes mellitus. For example, despite missing 1 or more days of laboratory data, a necessary piece of information for confirming the diagnosis, 7 men had a physician s diagnosis and 3 reported a history of using diabetic medication. Among the remaining 59 cases with complete data, the diagnosis of type 2 diabetes was confirmed in 57 (97%). SAMPLE in the Nurses Health Study and men in the Health Professionals Follow-up Study were excluded from the analysis if they reported a diagnosis of cancer before 1986 (3127 women and 2189 men); were missing information on demographics (31 women and 52 men), smoking (235 women and 1941 men), or BMI in 1986 (39404 women and 1103 men); were underweight (BMI in 1986 18.5; 1131 women and 151 men); or had outlying BMI (83 women and 33 men), leaving 77690 women and 46060 men for analysis. In addition, for all incident analyses, prevalent cases of the specific outcome or outcomes were excluded (eg, prevalent cases of diabetes were excluded from analyses of the incidence of diabetes). ANALYSIS All analyses were conducted with SAS software. 18 Logistic regression was used to assess the association between overweight and the 10-year risk of developing high cholesterol level, hypertension, gallstones, type 2 diabetes, heart disease, stroke, or colon cancer. All logistic regression models adjusted for age (in 10-year strata), smoking (never, past, or current), and race or ethnic group (white, African American, Hispanic, Asian, other, or missing). The BMI in 1986 was entered as a series of dichotomous variables, with 18.5 to 24.9 serving as the referent. In the primary analyses, the other BMI categories were 25.0 to 29.9, 30.0 to 34.9, and 35.0 or more. To investigate whether the risk was uniformly low in the referent group, subanalyses were run with the referent group restricted to a BMI of 18.5 to 21.9, and an additional dichotomous term for BMI of 22.0 to 24.9 was added to the logistic regression models. To assess the risk of developing more than 1 condition, the sample was stratified by the presence of a diagnosis of hypertension or high cholesterol level, and the proportion of participants with 0, 1, or more than 1 diagnosis was calculated within the category of BMI (ie, 18.5-24.9, 25.0-29.9, 30.0-34.9, and 35.0). All P values are 2-sided, with P.05 considered statistically significant. Table 1. Demographics of in the Nurses Health Study and in the Health Professionals Follow-up Study (n = 77 690) (n = 46 060) Mean, age, y (SD) 52.9 (7.1) 54.5 (9.8) Race/ethnic group, No. (%) White 59 746 (94.1)* 42 837 (93.0)* African American 874 (1.4)* 463 (1.0)* Hispanic 424 (0.7)* Asian 525 (0.8)* 821 (1.8)* Other 1907 (3.0)* 1142 (2.5)* Missing 14 214 (18.3) 797 (1.7), No. (%) 18.5-24.9 43 703 (56.3) 21 298 (46.2) 25.0-29.9 22 494 (29.0) 20 964 (45.5) 30.0-34.9 7909 (10.2) 3231 (7.0) 35.0 3584 (4.6) 567 (1.2) Smoking status, No. (%) Never 34 193 (44.0) 21 449 (46.6) Past 27 111 (34.9) 20 049 (43.5) Current 16 386 (21.1) 4562 (9.9) *Percentage of the individuals who provided information on race. Percentage of the individuals in the sample. diabetes, gallstones, hypertension, and heart disease increased with severity of overweight. To test whether the risk of developing an outcome was uniformly low in the healthy weight range, the reference group was redefined as having a BMI between 18.5 and 21.9, and the risks associated with a BMI between 22.0 and 24.9 were assessed in the logistic regression model. and men (Table 4) with a BMI between 22.0 and 24.9 were significantly more likely than their leaner peers to develop at least 1 of the morbidities. In addition, the risks associated with higher BMIs (ie, 25.0) increased as a result of restricting the reference group. For example, women with a BMI of 35.0 or more were at a 17-fold increase in risk of being diagnosed as having diabetes when the reference category was 18.5 to 24.9; that risk increased to 30-fold when the reference group was redefined as 18.5 to 21.9. Not only did the risk of developing diabetes, gallstones, hypertension, colon cancer, heart disease, and stroke increase with degree of overweight (Table 3), but also the risk of developing more than 1 outcome increased with weight category. Among women and men with a diagnosis of hypertension or high cholesterol level, the risk of developing additional morbidities increased across categories of BMI (Table 5). For example, the proportion of women with 1 or more incident morbidities increased from approximately 11% among the leanest women to 25% among the heaviest (P.001) (Table 5). A similar pattern was seen among women and men 1583

Table 2. Distribution of Disease Incidence by Period Among 77 690 in the Nurses Health Study and 46 060 in the Health Professionals Follow-up Study Disease Never, No. Before After Cumulative Incidence, 1986-1996, % Never, No. Before After Cumulative Incidence, 1986-1996, % Diabetes 74 578 1730 1382 1.9 43 313 1540 1207 2.8 Gallstones 67 491 4966 5233 7.8 42 782 1769 1509 3.5 Hypertension 51 301 17 909 8480 16.5 29 650 10 721 5689 19.2 High cholesterol level 47 037 7800 22 853 48.6 26 357 7136 12 567 47.7 Colon cancer 75 739 1430 521 0.7 45 673 346* 387 0.8 Heart disease 72 754 2449 2487 3.4 40 417 3524 2119 5.2 Stroke 76 674 378 638 0.8 45 183 393 484 1.1 *These 346 men had been diagnosed as having colon cancer when they enrolled in the study. All people with cancer at baseline were excluded from the sample eligible for analysis; thus, the numbers in this cell sum to greater than the size of the sample for analysis. Table 3. Ten-Year Risk (1986-1996) of Developing an Obesity-Related Morbidity Among 77 690 Female Nurses and 46 060 Male Health Professionals in the United States Adjusted Odds Ratios (95% CI)* Diabetes Gallstones Hypertension High Cholesterol Level Colon Cancer Heart Disease Stroke 10-y risk of developing disease, % 5 6 14 58 0.6 3 0.5 25.0 Referent Referent Referent Referent Referent Referent Referent 25.0-29.9 4.6 (3.9-5.4) 1.9 (1.7-2.0) 1.7 (1.6-1.8) 1.1 (1.1-1.2) 1.2 (1.0-1.5) 1.4 (1.2-1.5) 1.2 (1.0-1.4) 30.0-34.9 10.0 (8.4-11.8) 2.5 (2.3-2.7) 2.1 (1.9-2.2) 0.9 (0.9-1.0) 1.3 (1.0-1.7) 1.5 (1.3-1.7) 1.0 (0.8-1.4) 35.0 17.0 (14.2-20.5) 3.0 (2.7-3.3) 2.3 (2.1-2.6) 0.7 (0.6-0.7) 1.8 (1.3-2.6) 1.5 (1.3-1.8) 1.1 (0.8-1.7) 10-y risk of developing disease, % 8 13 13 46 0.5 4 1 25.0 Referent Referent Referent Referent Referent Referent Referent 25.0-29.9 3.5 (2.9-4.1) 1.4 (1.3-1.6) 1.7 (1.6-1.8) 1.3 (1.2-1.3) 1.2 (1.0-1.5) 1.5 (1.4-1.7) 1.2 (1.0-1.5) 30.0-34.9 11.2 (9.3-13.6) 2.3 (1.9-2.7) 2.7 (2.4-3.0) 1.2 (1.1-1.3) 1.7 (1.2-2.4) 2.0 (1.7-2.3) 2.0 (1.5-2.7) 35.0 23.4 (19.4-33.2) 2.9 (2.1-4.1) 3.0 (2.3-3.9) 1.3 (1.1-1.6) 1.3 (0.5-3.2) 2.2 (1.5-3.1) 2.3 (1.2-4.4) *Adjusted for age, smoking status, and race. CI indicates confidence interval. Risk, estimated from a logistic regression model, for a 50- to 59-year-old woman or man who is white, never smoked, and has a body mass index less than 25. without a history of hypertension or high cholesterol level. Among the men, but not the women, the risk of developing morbidities was lower in participants without a history of hypertension or high cholesterol level. Nevertheless, the proportion who developed 1 or more diseases increased with BMI. COMMENT During 10 years of follow-up, the incidence of diabetes, gallstones, hypertension, and heart disease in both men and women, and of colon cancer (women only) and stroke (men only), increased with BMI in 1986. Even adults who were overweight but not obese (ie, 25.0 BMI 29.9) were significantly more likely than their leaner peers to develop 1 or more of these diseases. Although there has been debate about whether the relationship between weight and risk of death is linear, J-shaped, or U-shaped, the results have consistently shown that adults with BMI greater than 30.0 are at increased risk of death. 8,19-21 Among 45- to 75-year-old men and women in the American Cancer Society s Cancer Prevention Study I, the risk of death increased linearly with BMI among the never smokers. The risk was particularly pronounced for death from cardiovascular disease and among men. 21 Manson et al 8 also observed a linear association between BMI and mortality during 16 years of follow-up among 15195 women who were never smokers in the Nurses Health Study. However, several other studies have observed that the risk was elevated in lowweight, as well as in overweight, adults 20 or did not increase significantly until BMI was greater than 27.0. 22 Although mortality is a clearly defined outcome, the results of mortality analyses can be difficult to interpret. Except for diseases that are almost always fatal regardless of treatment, mortality is a function of incidence of disease, stage of illness at diagnosis, and effectiveness of treatment. Many forms of cancer and cardiovascular disease are treatable by either pharmacotherapy or intervention (ie, angioplasty or surgery); thus, the relationship between excess weight and death from cancer or cardiovascular disease does not necessarily translate to 1584

Table 4. Ten-Year Risk (1986-1996) of Developing an Obesity-Related Morbidity Among 77 690 Female Nurses and 46 060 Male Health Professionals in the United States Adjusted Odds Ratios (95% CI)* Diabetes Gallstones Hypertension High Cholesterol Level Colon Cancer Heart Disease Stroke 10-y risk of developing disease, % 0.5 6 14 58 0.6 3 0.5 18.5-21.9 Referent Referent Referent Referent Referent Referent Referent 22.0-24.9 2.2 (1.7-3.1) 1.4 (1.3-1.6) 1.4 (1.3-1.5) 1.3 (1.2-1.3) 1.3 (1.0-1.7) 1.2 (1.1-1.4) 0.9 (0.7-1.1) 25.0-29.9 8.1 (6.1-10.7) 2.3 (2.1-2.5) 2.1 (1.9-2.2) 1.3 (1.3-1.4) 1.3 (1.0-1.7) 1.5 (1.4-1.7) 1.0 (0.8-1.3) 30.0-34.9 17.8 (13.4-23.7) 3.2 (2.8-3.5) 2.6 (2.4-2.8) 1.0 (1.0-1.1) 1.5 (1.1-2.1) 1.7 (1.4-1.9) 0.9 (0.7-1.3) 35.0 30.1 (22.5-40.5) 3.7 (3.3-4.2) 2.9 (2.6-3.3) 0.8 (0.7-0.8) 2.1 (1.4-3.1) 1.7 (1.4-2.1) 1.0 (0.7-1.5) 10-y risk of developing disease, % 8 13 13 46 0.5 4 1 18.5-21.9 Referent Referent Referent Referent Referent Referent Referent 22.0-24.9 1.8 (1.2-2.7) 1.2 (0.9-1.4) 1.5 (1.3-1.7) 1.3 (1.2-1.4) 1.9 (1.1-3.1) 1.1 (1.0-1.4) 1.1 (0.8-1.6) 25.0-29.9 5.6 (3.7-8.4) 1.6 (1.3-2.0) 2.4 (2.1-2.7) 1.6 (1.5-1.7) 2.0 (1.2-3.3) 1.7 (1.4-2.0) 1.3 (0.9-1.9) 30.0-34.9 18.2 (11.9-27.8) 2.5 (2.0-3.3) 3.8 (3.3-4.5) 1.5 (1.3-1.7) 2.9 (1.6-5.0) 2.2 (1.8-2.8) 2.1 (1.4-3.3) 35.0 41.2 (25.9-65.4) 3.3 (2.2-4.8) 4.2 (3.2-5.6) 1.6 (1.3-2.0) 2.2 (0.8-6.0) 2.4 (1.6-3.5) 2.5 (1.2-5.1) *Adjusted for age, smoking status, and race. CI indicates confidence interval. Risk, estimated from a logistic regression model, for a 50- to 59-year-old woman or man who is white, never smoked, and has a body mass index less than 25. Table 5. Distribution of Number of Incident Morbidities* by Body Mass Index Status Among US and % of Individuals by No. of Morbidities With High Cholesterol or High Blood Pressure Without High Cholesterol or High Blood Pressure Body Mass Index, kg/m 2 0 1 1 0 1 1 18.5-24.9 88.9 10.4 0.8 92.7 7.0 0.3 25.0-29.9 82.7 15.3 1.9 87.3 12.1 0.6 30.0-34.9 78.8 18.7 2.6 79.7 18.5 1.8 35.0 75.1 19.9 5.0 74.0 23.1 2.9 18.5-24.9 90.0 9.3 0.7 94.9 4.9 0.2 25.0-29.9 84.8 13.8 1.3 91.9 7.7 0.4 30.0-34.9 76.1 21.0 2.8 86.0 13.1 0.8 35.0 66.6 29.9 3.5 81.5 14.6 3.9 *Incident heart disease, stroke, diabetes, gallstones, or colon cancer. n = 41 578 with and 25 788 without high cholesterol level or high blood pressure. n = 22 420 with and 17 408 without high cholesterol level or high blood pressure. the same relationship with the development of cancer or cardiovascular disease. Moreover, several chronic diseases, such as hypertension and hypercholesterolemia, increase the risk of cardiovascular disease, but these conditions rarely are the direct cause of death. Nevertheless, both conditions have substantial economic and emotional costs because of their high prevalence. Because of the focus on mortality rather than morbidity as the outcome, less lethal diseases that may have important costs associated with them have a minimal impact on the results, thus highlighting why morbidity is an important outcome when the effects of obesity are studied. Our group previously reported on the health consequences of obesity observed in the Nurses Health Study 3,4,7,8 and the Health Professionals Follow-up Study. 23-25 Other investigators have also observed that overweight is predictive of developing type 2 diabetes, 26,27 hypertension, 28,29 dyslipidemia, 30 coronary heart disease, 31 stroke, 32 gallbladder disease, 33 osteoarthritis, 34,35 sleep apnea and respiratory problems, 36 and certain cancers. 37 Although an increase in risk is found across studies, the magnitude of the risk is difficult to compare because it has been classified in a variety of ways. Because there is a near-linear relationship between BMI and risk of developing type 2 diabetes, hypertension, and gallstones, the choice of how the reference group is defined can have a large impact on the results. The higher the BMI cutoff is for the reference group, the lower the risks will appear to be in the higher weight 1585

groups because people at increased risk have been placed in the reference group. One strength of our study is that the same BMI cutoffs were used as predictors of 7 morbidities. Morever, the weight classification we used was that espoused by the US dietary guidelines, 16 so the categories have inherent meaning. Our observation that women and men who have a BMI between 25.0 and 29.9 are at significantly increased risk of developing numerous health conditions offers support for lowering the overweight cutoff from a BMI of 27.0 to that of 25.0 in the recent weight guidelines from the US Department of Agriculture. Moreover, our finding that men and women in the upper half of the healthy weight category (ie, BMI between 22.0 and 24.9) are significantly more likely than their leaner peers to develop health problems highlights the necessity of counseling patients who are in the healthy weight range to maintain their weight or increase their physical activity levels. Because few people are able to lose weight and maintain the weight loss, it is important to intervene early, before the person has developed a serious weight problem. Although treatment for obesity is recommended only for overweight individuals with a BMI of 30.0 or more, or of 27.0 or more if they have other risk factors for disease, 38 it may be prudent to counsel slightly leaner patients if they are gaining weight, as well as patients who are overweight but do not meet the treatment cutoffs (ie, BMI of 25.0-26.9), on how to modify their diet and physical activity to control their weight. Accepted for publication December 4, 2000. This study was supported by Roche Pharmaceutical, Basel, Switzerland, and Nutley, NJ, and by research grants CA40356, HL35464, and CA55075 from the National Institutes of Health, Bethesda, Md. In addition, Drs Field, Laird, and Colditz were partially supported by the Boston Obesity Nutrition Research Center (grant DK 46200). Corresponding author and reprints: Alison E. Field, ScD, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115 (e-mail: Alison.Field@channing.harvard.edu). REFERENCES 1. Flegal KM, Caroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes. 1998;22:39-47. 2. Centers for Disease Control and Prevention. Update: prevalence of overweight among children, adolescents, and adults United States, 1988-1994. MMWR Morb Mortal Wkly Rep. 1997;46:199-202. 3. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882-889. 4. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278:1407-1411. 5. Tornberg SA, Carstensen JM. Relationship between Quetelet s index and cancer of the breast and female genital tract in 47,000 women followed for 25 years. Br J Cancer. 1994;69:358-361. 6. Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol. 1998;148:234-240. 7. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol. 1990;132:501-513. 8. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-685. 9. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341:427-434. 10. Witteman JCM, Willett WC, Stampfer MJ, et al. Moderate alcohol consumption and increased risk of systemic hypertension. Am J Cardiol. 1990;65:633-637. 11. Davis MA, Ettinger WH, Neuhaus JM, Hauck WW. Sex differences in osteoarthritis of the knee: the role of obesity. Am J Epidemiol. 1988;127:1019-1030. 12. Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol. 1994;139:119-129. 13. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Relative weight, diet and risk of symptomatic gallstones in middle-aged women. N Engl J Med. 1989;321:563-569. 14. Van Itallie TB. Obesity: adverse effects on health and longevity. Am J Clin Nutr. 1979;32:2723-2733. 15. Mann GV. The influence of obesity on health. N Engl J Med. 1974;291:178-185, 226-232. 16. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 1995. Washington, DC: US Dept of Health and Human Services and US Dept of Agriculture; 1995:10-12. 17. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk of factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900. 18. SAS Institute Inc. SAS User s Guide: Statistics. 4th ed. Cary, NC: SAS Institute Inc; 1990. 19. Seidell JC, Verschuren WM, van Leer EM, Kromhout D. Overweight, underweight, and mortality: a prospective study of 48287 men and women. Arch Intern Med. 1996;156:958-963. 20. Durazo-Arvizu RA, McGee DL, Cooper RS, Liao Y, Luke A. Mortality and optimal body weight in a sample of the US population. Am J Epidemiol. 1998;147:739-749. 21. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body mass index and mortality. N Engl J Med. 1998;338:1-7. 22. Sorkin JD, Muller D, Andres R. Body mass index and mortality in Seventh-day Adventist men: a critique and re-analysis. Int J Obes Relat Metab Disord. 1994; 18:752-754. 23. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol. 1996; 144:1143-1150. 24. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141:1117-1127. 25. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:557-563. 26. Colditz GA, Willett WC, Rotnitsky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486. 27. Holbrook TL, Barrett-Conner E, Wingard DL. The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Int J Obes. 1989;13:723-729. 28. Field AE, Byers T, Hunter DJ, et al. Weight cycling, weight gain, and risk of hypertension in women. Am J Epidemiol. 1999;150:573-579. 29. Folsom AR, Prineas RJ, Kaye SA, Soler JT. Body fat distribution and selfreported prevalence of hypertension, heart attack, and heart disease in older women. Int J Epidemiol. 1989;18:361-367. 30. Pi-Sunyer FX. Comorbidities of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999;31(11, suppl):s602-s608. 31. Harris TB, Ballard-Barbasch R, Madans J, Makue DM, Feldman JJ. Overweight, weight loss, and risk of coronary heart disease in older women: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1993;137:1318-1327. 32. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA. 1997;277:1539-1545. 33. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652-658. 34. Cooper C, Inskip H, Croft P, et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol. 1998;147:516-522. 35. Manninen P, Riihimaki H, Heliovaara M, Makela P. Overweight, gender and knee osteoarthritis. Int J Obes Relat Metab Disord. 1996;20:595-597. 36. Bray GA. Health hazards of obesity. Endocrinol Metab Clin North Am. 1996;25: 907-919. 37. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;58:1855-1867. 38. NHLBI Obesity Initiative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6(suppl 2):51s-209s. 1586